AB1315 BIOLOGICAL THERAPY CAN IMPROVE CORONARY ARTERY LESIONS AND IMMUNOTHERAPY REDUCES THE OCCURREN...
AB1315 BIOLOGICAL THERAPY CAN IMPROVE CORONARY ARTERY LESIONS AND IMMUNOTHERAPY REDUCES THE OCCURRENCE RATE OF MACE IN TAKAYASU ARTERITIS PATIENTS WITH CORONARY ARTERY LESIONS
About this item
Full title
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background:Takayasu arteritis（TA）can involve coronary artery lesions. Previous studies have shown that the incidence of TA complicated with coronary artery lesion is 3.6%-53.2%[1,2],The incidence of acute myocardial infarction is 5.9%-12.06%[3, 4]. Tocilizumab treatment could significantly improved TA with coronary artery lesion[5]. But,the pathoge...
Alternative Titles
Full title
AB1315 BIOLOGICAL THERAPY CAN IMPROVE CORONARY ARTERY LESIONS AND IMMUNOTHERAPY REDUCES THE OCCURRENCE RATE OF MACE IN TAKAYASU ARTERITIS PATIENTS WITH CORONARY ARTERY LESIONS
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3100843723
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100843723
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.996
